PortfoliosLab logoPortfoliosLab logo
OLMA vs. CVNA
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

OLMA vs. CVNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Olema Pharmaceuticals, Inc. (OLMA) and Carvana Co. (CVNA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, OLMA achieves a -57.24% return, which is significantly lower than CVNA's -22.28% return.


OLMA

1D
-15.89%
1M
-25.35%
YTD
-57.24%
6M
-60.63%
1Y
144.34%
3Y*
23.54%
5Y*
-17.30%
10Y*

CVNA

1D
-7.61%
1M
-14.27%
YTD
-22.28%
6M
-14.18%
1Y
-1.04%
3Y*
175.53%
5Y*
3.67%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

OLMA vs. CVNA - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
OLMA
Olema Pharmaceuticals, Inc.
-57.24%328.82%-58.45%472.65%-73.82%-80.53%-1.88%
CVNA
Carvana Co.
-22.28%107.52%284.13%1,016.88%-97.96%-3.24%5.52%

Correlation

The correlation between OLMA and CVNA is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.11

Correlation (3Y)
Calculated over the trailing 3-year period

0.17

Correlation (5Y)
Calculated over the trailing 5-year period

0.23

Correlation (All Time)
Calculated using the full available price history since Nov 20, 2020

0.22

The correlation between OLMA and CVNA shifts across timeframes, from 0.11 (1 year) to 0.23 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

OLMA:

$1.10B

CVNA:

$9.71B

EPS

OLMA:

-$2.03

CVNA:

$8.69

PB Ratio

OLMA:

2.29

CVNA:

2.61

Total Revenue (TTM)

OLMA:

$0.00

CVNA:

$22.52B

Gross Profit (TTM)

OLMA:

-$187.00K

CVNA:

$4.50B

EBITDA (TTM)

OLMA:

-$197.79M

CVNA:

-$116.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

OLMA vs. CVNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

OLMA
OLMA Risk / Return Rank: 7676
Overall Rank
OLMA Sharpe Ratio Rank: 6868
Sharpe Ratio Rank
OLMA Sortino Ratio Rank: 9090
Sortino Ratio Rank
OLMA Omega Ratio Rank: 8888
Omega Ratio Rank
OLMA Calmar Ratio Rank: 6868
Calmar Ratio Rank
OLMA Martin Ratio Rank: 6666
Martin Ratio Rank

CVNA
CVNA Risk / Return Rank: 3939
Overall Rank
CVNA Sharpe Ratio Rank: 3939
Sharpe Ratio Rank
CVNA Sortino Ratio Rank: 3838
Sortino Ratio Rank
CVNA Omega Ratio Rank: 3838
Omega Ratio Rank
CVNA Calmar Ratio Rank: 3939
Calmar Ratio Rank
CVNA Martin Ratio Rank: 4040
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

OLMA vs. CVNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Olema Pharmaceuticals, Inc. (OLMA) and Carvana Co. (CVNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


OLMACVNADifference

Sharpe ratio

Return per unit of total volatility

0.90

-0.02

+0.92

Sortino ratio

Return per unit of downside risk

3.26

0.40

+2.86

Omega ratio

Gain probability vs. loss probability

1.41

1.05

+0.36

Calmar ratio

Return relative to maximum drawdown

1.46

0.01

+1.45

Martin ratio

Return relative to average drawdown

3.12

0.01

+3.10

OLMA vs. CVNA - Sharpe Ratio Comparison

The current OLMA Sharpe Ratio is 0.90, which is higher than the CVNA Sharpe Ratio of -0.02. The chart below compares the historical Sharpe Ratios of OLMA and CVNA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


OLMACVNADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.90

-0.02

+0.92

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.16

0.03

-0.19

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.23

0.46

-0.68

Drawdowns

OLMA vs. CVNA - Drawdown Comparison

The maximum OLMA drawdown since its inception was -96.26%, roughly equal to the maximum CVNA drawdown of -98.99%. Use the drawdown chart below to compare losses from any high point for OLMA and CVNA.


Loading charts...

Drawdown Indicators


OLMACVNADifference

Max Drawdown

Largest peak-to-trough decline

-96.26%

-98.99%

+2.73%

Max Drawdown (1Y)

Largest decline over 1 year

-70.16%

-41.21%

-28.95%

Max Drawdown (3Y)

Largest decline over 3 years

-82.15%

-53.47%

-28.68%

Max Drawdown (5Y)

Largest decline over 5 years

-93.36%

-98.99%

+5.63%

Current Drawdown

Current decline from peak

-80.39%

-31.45%

-48.94%

Average Drawdown

Average peak-to-trough decline

-74.98%

-38.12%

-36.86%

Ulcer Index

Depth and duration of drawdowns from previous peaks

32.85%

18.12%

+14.73%

Volatility

OLMA vs. CVNA - Volatility Comparison

Olema Pharmaceuticals, Inc. (OLMA) has a higher volatility of 21.98% compared to Carvana Co. (CVNA) at 15.37%. This indicates that OLMA's price experiences larger fluctuations and is considered to be riskier than CVNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


OLMACVNADifference

Volatility (1M)

Calculated over the trailing 1-month period

21.98%

15.37%

+6.61%

Volatility (6M)

Calculated over the trailing 6-month period

55.92%

42.93%

+12.99%

Volatility (1Y)

Calculated over the trailing 1-year period

161.50%

59.41%

+102.09%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

107.97%

111.17%

-3.20%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

106.45%

99.28%

+7.17%

Dividends

OLMA vs. CVNA - Dividend Comparison

Neither OLMA nor CVNA has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

OLMA vs. CVNA - Financials Comparison

This section allows you to compare key financial metrics between Olema Pharmaceuticals, Inc. and Carvana Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B6.00B202220232024202520260
6.43B
(OLMA) Total Revenue
(CVNA) Total Revenue
Values in USD except per share items

Frequently Asked Questions


OLMA and CVNA have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

OLMA has higher volatility (21.98%) compared to CVNA (15.37%). In terms of maximum drawdown, OLMA dropped -96.26% vs CVNA's -98.99%.

OLMA currently has the higher Sharpe Ratio (0.90 vs -0.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for OLMA and CVNA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer